Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Indivior    INDV   GB00BRS65X63

INDIVIOR

(INDV)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Indivior PLC : annual earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/11/2019 | 09:15am EDT

The company will report its earnings for FY 2018 on 02/14/2019. Generally, the company reports earnings in line with the consensus. In recent months, the 4 analysts from Thomson Reuters consensus have revised their EPS estimates downward.

Annual earnings per share is expected at 0.35 USD for 2018 (+ 342.9% from 2017). A summary of annual publications and estimates is available below.

Annual results2015201620172018 (e)2019 (e)
Sales
Million $
Released
Forecast
Spread
1 014
1 008
0,61%
1 058
1 066
-0,76%
1 093
1 104
-1,0%

998

559
Operating income (EBITDA)
Million $
Released
Forecast
Spread
417
401
4,0%
401
410
-2,3%
416
429
-3,0%

339

31,7
Operating profit (EBIT)
Million $
Released
Forecast
Spread
377
377
-0,11%
387
368
5,0%
403
412
-2,1%

321

24,9
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
285
309
-7,6%
98,0
147
-33%
137
351
-61%

286

21,9
Net income
Million $
Released
Forecast
Spread
228
225
1,4%
35,0
60,3
-42%
58,0
260
-78%

253

32,4
EPS
 $
Released
Forecast
Spread
0,31
0,31
-0,32%
0,05
0,15
-66%
0,08
0,35
-77%

0,35

-0,03
Announcement Date02/18/201602/22/201702/15/2018

© MarketScreener.com 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INDIVIOR
04/16INDIVIOR : US charges drugmaker Indivior, Reckitt over opioid healthcare fraud
AQ
04/15LONDON STOCK EXCHANGE : London's FTSE 100 subdued, IWG lifts midcaps
RE
04/11LONDON STOCK EXCHANGE : Brexit delay lifts mid-caps to six-month high; growth fe..
RE
04/11INDIVIOR : RB Group Plc - US Justice Department indictment of Indivior Plc
AQ
04/11INDIVIOR : Virginia drug company charged in billion-dollar opioid marketing frau..
AQ
04/11Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptio..
RE
04/11Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptio..
RE
04/11U.K. Drugmaker Charged -- WSJ
DJ
04/11INDIVIOR : FTSE 100 inches lower as Indivior share price tanks
AQ
04/11INDIVIOR : shares collapse after US fraud indictment
AQ
More news
Financials ($)
Sales 2019 454 M
EBIT 2019 20,0 M
Net income 2019 -12,0 M
Finance 2019 115 M
Yield 2019 -
P/E ratio 2019 -
P/E ratio 2020 7,40
EV / Sales 2019 0,61x
EV / Sales 2020 0,55x
Capitalization 390 M
Chart INDIVIOR
Duration : Period :
Indivior Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INDIVIOR
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 1,77 $
Spread / Average Target 232%
EPS Revisions
Managers
NameTitle
Shaun Thaxter Chief Executive Officer & Executive Director
Howard H. Pien Chairman
Mark Crossley Chief Financial Officer & Executive Director
Christian Heidbreder Chief Scientific Officer
Ingo Elfering Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
INDIVIOR-63.51%390
WUXI APPTEC CO LTD24.17%16 074
MERCK KGAA4.22%13 625
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD34.56%10 499
KYOWA HAKKO KIRIN CO LTD0.59%9 837
JAZZ PHARMACEUTICALS PLC3.61%7 328